Haemonetics Corp. buy BTIG Research
Start price
06.02.26
/
50%
€48.40
Target price
06.02.27
€74.64
Performance (%)
40.50%
Price
26.06.26
€68.00
Summary
This prediction is currently active. With a performance of 40.50% the BUY prediction by BTIG_Research is a big success. This prediction currently runs until 06.02.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 5.426% | 5.426% |
| iShares Core DAX® | -1.358% | -2.329% |
| iShares Nasdaq 100 | -3.700% | -1.242% |
| iShares Nikkei 225® | -2.512% | 6.914% |
| iShares S&P 500 | -1.662% | -0.643% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€72.00
09.01.26
09.01.26
€75.54
09.01.27
09.01.27
-5.56%
26.06.26
26.06.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
18.26%
26.06.26
26.06.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25